Polycystic ovaries (PCO), identified by ultrasonography, may be present in as many as 23% of otherwise normal women not manifesting any of the clinical signs of obesity, hirsutism and oligomenorrhoea.' Furthermore, a third of women being investigated for infertility in a recent study were shown to have PCO by laparo-3 Yen SSC. The polycystic ovary syndrome. Clin Endocrinol 1980; 12: 177-207 4 Eden JA, Carter GD, Jones J, Alaghband-Zadeh J, Pawson M. Factors influencing the free androgen index in a group of subfertile women with normal ovaries. Ann Clin Biochem 1988; 25: 350-3 5 Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293: 355-9
copy.^ Thus this condition would appear to be far more common than hitherto suspected, and could account for a large proportion of infertility cases. The condition is usually associated with elevated concentrations of LH and androgens, including testosterone,' but some indices such as free androgen index may be influenced by factors such as age and obesity4 and LH concentrations are not always raised.
The ovaries and the adrenal glands are the main sources of androgens in women. Increased stimulation of the ovaries by LH during the follicular phase could account for raised androgen concentrations, in which case precursor progestogens should also be increased. Late onset congenital adrenal hyperplasia due to mild (subclinical) 2 1 a-hydroxylase deficiency might also result in increased concentrations of progesterone and I7a-hydroxyprogesterone, some of which would be converted to androgens. Since low dose progestogen pills can be used t o reduce fertility in normal women, it is possible that raised endogenous progestogen concentrations in women with PCO during the follicular phase could contribute to their infertility.
We have compared serum progesterone, 17ahydroxyprogesterone and various androgen indices during the early part of the follicular phase in women with PCO and in women with normal ovaries, since during this part of the cycle the concentrations of these steroids are normally low.
METHODS
Seventeen young female medical students initially volunteered to take part in the study which had Medical Ethical Committee approval. All the women underwent abdominal ultrasonography, and were subsequently classified as negative (n = 10) or positive (n = 7) for the presence of polycystic ovaries using the criteria of Adams et u I .~ A blood sample was taken between days 1-5 of the cycle from each subject and the steroid concentrations subsequently determined using standard radioimmunoassay techniques.
The hormones measured were progesterone, 1 7a-hydroxyprogesterone, androstenedione, dehydroepiandrosterone sulphate and testosterone. In addition, sex hormone binding globulin (SHBG) concentrations were determined, and the ratio of testosterone to SHBG expressed as a percentage to give a value for the free androgen index (FAI). All samples for progesterone and 17a-hydroxyprogesterone were measured in the same batch. The within-assay coefficient of variation for progesterone at 1.039nmol/L was 12% while that for 17ahydroxyprogesterone at 1.003 nmol/L was 24%.
One woman, classified as having normal ovaries was subsequently found to have concentrations of hormones all well above those measured for the rest of the group. She was diagnosed as a probable late onset congenital adrenal hyperplasia and was not included in the analysis.
Values are given as mean & SEM and differences between the groups were determined using the Mann-Whitney U test. A probability of P < 0.05 was taken to indicate a significant difference between the groups.
RESULTS
Both groups had a similar age and body mass index (see Table 1 ). The various androgens were generally higher in the PCO group than in the normal women, the differences for the androstenedione and dehydroepiandrosterone sulphate levels of the two groups reaching statistical significance. The plasma SHBG concentration was slightly lower in the PCO women and consequently the free androgen index (FAI) was higher but the difference between the groups was not significant. The mean progesterone concentration was significantly higher ( P > 0.01) as was the 17ahydroxyprogesterone concentration ( P < 0.05) in the women with PCO.
DISCUSSION
The results of this study confirm that the presence of polycystic ovaries is far more common in the 'normal' young (medical student) population than hitherto appreciated (over 40% in this sample). Furthermore the results show that some plasma androgens are poor indicators of PCO in young women with low-normal body mass indices. Since the SHBG concentration is influenced by such factors as age and ~b e s i t y ,~ the use of the free androgen index is of little value in such women. Unfortunately, LH (another commonly used biochemical marker for PCO) was not measured in these women. On the other hand, measures of progesterone and I7a-hydroxy-progesterone concentrations during the early part of the follicular phase, when these hormones are normally low and stable, are clearly abnormally raised in the young women with PCO.
Since the early follicular phase progesterone concentration is raised in women with PCO it is possible that its actions on uterine epithelium and cervical secretions could be associated with the high incidence of infertility and subfertility in this condition.
